NCT04170946View on ClinicalTrials.gov

Talazoparib and Thoracic RT for ES-SCLC

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Lung CancerSmall-Cell Lung Cancer
Interventions
OTHER

Talazoparib in Combination with Low Dose Radiotherapy (RT)

Dose escalation model to determine the safety and MTD of talazoparib in combination with low dose RT.

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Center, University Health Network, Toronto

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Health Network, Toronto

OTHER